Table 5.

Comorbidity in patients with airflow limitation (malignant disease)

Gastrointestinal diseases (gastric cancer, esophageal cancer, colon cancer, etc)	71 (24.6%)
Otolaryngeal, head and neck diseases (laryngeal or pharyngeal cancer, thyroid cancer)	64 (22.1%)
Lung and mediastinal diseases (lung cancer, thymoma, etc)	53 (18.3%)
Urological diseases (bladder cancer, renal pelvic cancer, etc)	42 (14.5%)
Dermatologic diseases (basal cell carcinoma, malignant melanoma, etc)	17 (5.9%)
Hepatocellular and cholangiocellular carcinoma	14 (4.8%)
Breast cancer	11 (3.8%)
Hematological malignancy	8 (2.8%)
Gynecological malignancy	6 (2.1%)
Pancreas cancer	3 (1.0%)
Total	289 (100%)